Bay Leaf (Nelco Laboratories, Inc.)
Welcome to the PulseAid listing for the Bay Leaf drug offered from Nelco Laboratories, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Nelco Laboratories, Inc. |
NON-PROPRIETARY NAME: | Bay Leaf |
SUBSTANCE NAME: | LAURUS NOBILIS |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTRADERMAL; SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 1972-08-29 |
END MARKETING DATE: | 0000-00-00 |
Bay Leaf HUMAN PRESCRIPTION DRUG Details:
Item Description | Bay Leaf from Nelco Laboratories, Inc. |
LABELER NAME: | Nelco Laboratories, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.05(g/mL) |
START MARKETING DATE: | 1972-08-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 36987-1666_dec580ea-73db-4658-9de1-440c19bb42b7 |
PRODUCT NDC: | 36987-1666 |
APPLICATION NUMBER: | BLA102192 |
Other LAURUS NOBILIS Pharmaceutical Manufacturers / Labelers: